
GeoVax Labs, Inc.
NASDAQ:GOVX
Overview | Financials
Company Name | GeoVax Labs, Inc. |
Symbol | GOVX |
Currency | USD |
Price | 1.18 |
Market Cap | 16,330,610 |
Dividend Yield | 0% |
52-week-range | 1.03 - 11.18 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. David Alan Dodd |
Website | https://www.geovax.com |
An error occurred while fetching data.
About GeoVax Labs, Inc.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD